Home›Companies›Healthcare›Cresilon

Cresilon, Inc.

Makes bleeding-control gels for emergency care providers and veterinary surgeons.

Updated Nov 11, 2026·Latest SEC filing Jun 26, 2026·Suggest an edit

About Cresilon

Cresilon is a private company based in Brooklyn, New York. It has reported $157,901,161 raised in eight offerings on Form D since January 2018. Its chief executive is Joseph Landolina.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 24, 2026Apr 29, 2026amended Jun 26, 2026$28,999,199of $29.0M target217$133KDebt, OptionsRule 506(c)Form D/A ↗1 earlier filing
Nov 21, 2025Dec 8, 2025$6,683,401of $6.7M target55$121KEquityRule 506(c)Form D ↗
Apr 11, 2025Sep 5, 2025$17,172,969of $34.7M target95$180KSecurities on exerciseRule 506(b)Form D ↗
Apr 18, 2024Jan 31, 2025$24,999,967of $25.0M target237$105KEquity, OptionsRule 506(c)Form D ↗
Aug 3, 2023Oct 8, 2024$17,243,350of $38.0M target309$55,804Equity, Options, Securities on exerciseRule 506(b)Form D ↗
Dec 17, 2021Oct 18, 2022$24,999,999of $25.0M target308$81,169Equity, OptionsRule 506(c)Form D ↗
Jan 29, 2021Feb 16, 2021$24,464,276of $45.2M target170$143KEquityRule 506(b)Form D ↗
Dec 29, 2017Jan 12, 2018$13,338,000of $19.3M target55$242KEquityRule 506(b)Form D ↗
Total, eight offerings$157,901,161

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Cresilon's Form D filed Jun 26, 2026.

Joseph Landolina
Joseph Landolina
CEO, Co-founder and director
IM
Isaac Miller
EVP, Co-founder and director
SL
Scott Levine
Chief Financial Officer

Sources

  1. SECCresilon, Inc. Form D, filed Apr 29, 2026
  2. SECCresilon, Inc. filing history
  3. CompanyManagement
  4. CompanyMedia